Detailed information for compound 1698481

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 569.651 | Formula: C32H35N5O5
  • H donors: 5 H acceptors: 5 LogP: 2.47 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: Oc1ccc(cc1)C[C@@H](C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C(=O)N2)Cc1ccccc1)N
  • InChi: 1S/C32H35N5O5/c33-25(15-22-11-13-24(38)14-12-22)32(42)37-19-23-18-28(37)31(41)36-27(17-21-9-5-2-6-10-21)30(40)35-26(29(39)34-23)16-20-7-3-1-4-8-20/h1-14,23,25-28,38H,15-19,33H2,(H,34,39)(H,35,40)(H,36,41)/t23-,25-,26+,27+,28-/m0/s1
  • InChiKey: GCAAWBGPPHFVPO-XVYWXRPESA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni DNA topoisomerase II 0.0808 0.0983 0.5
Giardia lamblia DNA topoisomerase II 0.0766 0.0897 0.5
Plasmodium vivax DNA topoisomerase II, putative 0.0808 0.0983 1
Mycobacterium tuberculosis Integral membrane indolylacetylinositol arabinosyltransferase EmbC (arabinosylindolylacetylinositol synthase) 0.5206 1 1
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0546 0.0446 0.5
Leishmania major mitochondrial DNA topoisomerase II 0.0907 0.1186 1
Loa Loa (eye worm) hypothetical protein 0.0547 0.0447 0.4551
Plasmodium falciparum DNA topoisomerase 2 0.0808 0.0983 1
Mycobacterium leprae Probable integral membrane indolylacetylinositol arabinosyltransferase EmbB (arabinosylindolylacetylinositol synthase) 0.5206 1 0.5
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0907 0.1186 1
Mycobacterium tuberculosis Integral membrane indolylacetylinositol arabinosyltransferase EmbA (arabinosylindolylacetylinositol synthase) 0.5206 1 1
Mycobacterium ulcerans integral membrane indolylacetylinositol arabinosyltransferase EmbA 0.5206 1 1
Mycobacterium tuberculosis Integral membrane indolylacetylinositol arabinosyltransferase EmbB (arabinosylindolylacetylinositol synthase) 0.5206 1 1
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0546 0.0446 0.5
Loa Loa (eye worm) TOPoisomerase family member 0.0808 0.0983 1
Entamoeba histolytica DNA topoisomerase II, putative 0.0808 0.0983 0.5
Chlamydia trachomatis DNA gyrase subunit B 0.0471 0.0292 1
Toxoplasma gondii DNA topoisomerase 2, putative 0.0808 0.0983 1
Mycobacterium ulcerans integral membrane indolylacetylinositol arabinosyltransferase EmbB 0.5206 1 1
Trypanosoma brucei DNA topoisomerase ii 0.0907 0.1186 1
Treponema pallidum DNA gyrase, subunit B (gyrB) 0.0471 0.0292 0.5
Wolbachia endosymbiont of Brugia malayi DNA gyrase, topoisomerase II, B subunit, GyrB 0.0471 0.0292 0.5
Loa Loa (eye worm) hypothetical protein 0.0547 0.0447 0.4551
Echinococcus granulosus DNA topoisomerase 2 alpha 0.0808 0.0983 0.5
Brugia malayi Probable DNA topoisomerase II 0.0808 0.0983 0.5
Onchocerca volvulus Putative DNA topoisomerase 2, mitochondrial 0.0546 0.0446 0.5
Brugia malayi DNA gyrase/topoisomerase IV, A subunit family protein 0.0808 0.0983 0.5
Trichomonas vaginalis DNA topoisomerase II, putative 0.0808 0.0983 0.5
Echinococcus multilocularis DNA topoisomerase 2 alpha 0.0808 0.0983 0.5
Mycobacterium ulcerans integral membrane indolylacetylinositol arabinosyltransferase EmbC 0.5206 1 1
Brugia malayi DNA topoisomerase II, alpha isozyme 0.0808 0.0983 0.5
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0907 0.1186 1
Mycobacterium leprae Probable integral membrane indolylacetylinositol arabinosyltransferase EmbC (arabinosylindolylacetylinositol synthase) 0.5206 1 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.